Doxazosin Tablet
Product Images NDC 68084-862

18 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68084-862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp83601

Ahp83601
Doxazosin tablet imprints shown from both sides. One side is embossed with "APO" and the other side with "093" above and below a scored line. The tablet is white and round, with visible measurement scales in millimeters.*
FDA Label Image

Ahp85101

Ahp85101
Doxazosin 1 mg oral tablet, white and oblong, with imprint 'APO 094' visible on either side. Manufactured by American Health Packaging. The image includes a scale in millimeters showing the tablet size.*
FDA Label Image

Ahp86201

Ahp86201
Doxazosin 1 mg oral tablet, white, capsule-shaped, imprinted with "APO" on one side and "095" on the other side. Manufactured or labeled by American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Doxazosin, an active pharmaceutical ingredient. The diagram shows the molecular arrangement with rings, nitrogen atoms, and methoxy groups characteristic of Doxazosin's chemical formula.*
FDA Label Image

Table 3 Summary Of Effectiveness Data In Placebo-controlled Trials (Table3)

Table 3 Summary Of Effectiveness Data In Placebo-controlled Trials (Table3)
A data table summarizing effectiveness data from placebo-controlled trials of Doxazosin, showing symptom score and maximum flow rate changes across three studies. The table includes baseline and mean change values for placebo and Doxazosin doses (4 mg and 8 mg). A bar graph illustrates mean symptom score reductions and increases in maximum flow rate, highlighting statistically significant differences versus placebo.*
FDA Label Image

Figure 1 – Study 1 (Figure1)

Figure 1 – Study 1 (Figure1)
Two line graphs depicting clinical data for Doxazosin in comparison to placebo over a 14-week treatment period. The first graph shows mean change in total symptom score from baseline, with Doxazosin showing a greater reduction than placebo. The second graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with Doxazosin showing a larger increase versus placebo. Sample sizes (N) are 50 for Doxazosin and 47 for placebo. Statistical significance markers are included.*
FDA Label Image

1mg Doxazosin Tab 5x6 Carton (1mg Doxazosin Tab 5x6 Carton)

1mg Doxazosin Tab 5x6 Carton (1mg Doxazosin Tab 5x6 Carton)
Label for Doxazosin Tablets USP, 1 mg strength, oral tablet form. The packaging contains 30 tablets in a 5 x 6 count blister. Distributed by American Health Packaging, Columbus, Ohio. Includes storage instructions and barcode. NDC 68084-836-25 shown.*
FDA Label Image

1 mg Doxazosin Tablet Bliser, 6ud (1mg 6ud Blister)

1 mg Doxazosin Tablet Bliser, 6ud (1mg 6ud Blister)
Label for Doxazosin Tablet, USP 1 mg, an oral tablet manufactured and labeled by American Health Packaging, Columbus, OH. The label includes the drug name, strength, lot number 123456, and expiration date 12/15. Three identical labels are shown with barcodes and standard regulatory text.*
FDA Label Image

1mg Doxazosin Tab10x10 Carton (1mg Doxazosin Tab 10x10 Carton)

1mg Doxazosin Tab10x10 Carton (1mg Doxazosin Tab 10x10 Carton)
Doxazosin Tablets, USP 1 mg oral tablets packaging label. The label shows a package of 100 tablets (10 x 10) with dosage strength 1 mg. It includes storage information, a note that it is Rx only, the National Drug Code (NDC) 68084-836-01, and states the labeler as American Health Packaging, Columbus, Ohio. A QR code for current prescribing information is also visible.*
FDA Label Image

1 mg Doxazosin Tablet Blister 10ud (1mg 10ud Blister)

1 mg Doxazosin Tablet Blister 10ud (1mg 10ud Blister)
Label set for Doxazosin 1 mg tablets by American Health Packaging. Each label includes the product name, strength (1 mg), dosage form (tablet, USP), a barcode, expiration date, lot number placeholders, and the labeler information located in Columbus, Ohio.*
FDA Label Image

2mg Doxazosin Tab 5x6 Carton (2mg Doxazosin Tab 5x6 Carton)

2mg Doxazosin Tab 5x6 Carton (2mg Doxazosin Tab 5x6 Carton)
Label for Doxazosin Tablets, USP, 2 mg strength, in a package of 30 tablets. The product is identified by NDC 68084-851-25 and labeled for prescription use only. The label includes storage instructions, dosage caution, manufacturer and distributor information, and a QR code for current prescribing information. The labeler is American Health Packaging.*
FDA Label Image

2 mg Doxazosin Tablet Blister 6ud (2mg 6ud Blister)

2 mg Doxazosin Tablet Blister 6ud (2mg 6ud Blister)
Packaging label for Doxazosin tablets, USP, each with a strength of 2 mg. The label indicates oral tablets supplied by American Health Packaging, Columbus, OH. Lot and expiry details are included, along with barcodes and packaging identifiers.*
FDA Label Image

2mg Doxazosin Tab10x10 Carton (2mg Doxazosin Tab 10x10 Carton)

2mg Doxazosin Tab10x10 Carton (2mg Doxazosin Tab 10x10 Carton)
Label for Doxazosin Tablets, USP, 2 mg strength, supplied as 100 tablets (10 x 10) by American Health Packaging. The label includes NDC number 68084-851-01, storage instructions, dosage note, and a QR code for current prescribing information.*
FDA Label Image

2 mg Doxazosin Tablet Blister 10ud (2mg 10ud Blister)

2 mg Doxazosin Tablet Blister 10ud (2mg 10ud Blister)
Label sheet of Doxazosin tablets USP 2 mg by American Health Packaging, featuring multiple identical labels. Each label includes the proprietary and generic name, strength of 2 mg, dosage form as oral tablet, barcode, and manufacturer information from Columbus, Ohio. Expiry date and lot number are marked as placeholders.*
FDA Label Image

4mg Doxazosin Tab 5x6 Carton (4mg Doxazosin Tab 5x6 Carton)

4mg Doxazosin Tab 5x6 Carton (4mg Doxazosin Tab 5x6 Carton)
Label for Doxazosin Tablets, USP 4 mg, oral tablets supplied in a 30-count package (5 blisters of 6 tablets). Label shows NDC 68084-862-25 and indicates Rx only. Distributed by American Health Packaging, Columbus, Ohio. The label includes storage instructions and a QR code for current prescribing information.*
FDA Label Image

4 mg Doxazosin Tablet Blister 6ud (4 mg 6ud Blister)

4 mg Doxazosin Tablet Blister 6ud (4 mg 6ud Blister)
Label for Doxazosin Tablet USP 4 mg, oral dosage form, manufactured by American Health Packaging. The label includes lot number 123456 and an expiry date of 12/15. The label displays the proprietary and generic name, tablet strength, packaging details, and a barcode.*
FDA Label Image

4mg Doxazosin Tab10x10 Carton (4mg Doxazosin Tab 10x10 Carton)

4mg Doxazosin Tab10x10 Carton (4mg Doxazosin Tab 10x10 Carton)
Label for Doxazosin Tablets USP, 4 mg strength, oral tablet dosage form. The label shows a package size of 100 tablets (10 blister packs of 10 tablets each). It includes storage instructions, a QR code for prescribing information, and notes that it is a prescription-only drug distributed by American Health Packaging.*
FDA Label Image

4 mg Doxazosin Tablet Blister 10ud (4mg 10ud Blister)

4 mg Doxazosin Tablet Blister 10ud (4mg 10ud Blister)
Doxazosin Tablet, USP 4 mg label showing multiple barcode labels. Each label includes the product name, strength, barcode, and manufacturer information from American Health Packaging, Columbus, Ohio. Expiry and lot number fields are indicated but not filled in.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.